Multiple Myeloma Clinical Trials

ReadTheTrial indexes 5 studies for Multiple Myeloma. The most common development stage is Phase 1 (2 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

5 clinical trials found for Multiple Myeloma.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 2
40%
Phase 2 2
40%
N/A 1
20%

Trial Status Breakdown

Trials for Multiple Myeloma

A Phase 1b Clinical Trial of CRISPR Delivered Anti-BCMA Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Multiple Myeloma

NCT07340853 · RECRUITING · Phase 1

A Phase 2 Adaptive Study of Subcutaneous Daratumumab, Once Weekly Carfilzomib, and Dexamethasone (DKd) in Patients With High-Risk Smoldering Multiple Myeloma

NCT04933539 · ACTIVE NOT RECRUITING · Phase 2

Zn-DDC to Target Hypoxia-NFkappaB-CSCs Pathway and Improve the Treatment Outcomes of Haematological Malignancies - A Translation Bench Study

NCT04234022 · RECRUITING · N/A

A Phase 1 Dose Escalation and Cohort Expansion Study of the Safety and Efficacy of Anti-BCMA Allogeneic CRISPR-Cas9-Engineered T Cells (CTX120) in Subjects With Relapsed or Refractory Multiple Myeloma

NCT04244656 · TERMINATED · Phase 1

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

NCT01067287 · COMPLETED · Phase 2

Frequently Asked Questions

What clinical trials are available for Multiple Myeloma?

There are 5 clinical trials listed for Multiple Myeloma. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Multiple Myeloma trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Multiple Myeloma trials in?

Current Multiple Myeloma trials are distributed across: Phase 1 (2), Phase 2 (2), N/A (1).

Find More Trials